Role of NF-kappa B in the pathogenesis of diabetes and its associated complications (Q37611364)

21 August 2017

1 reference

title

Role of NF-kappa B in the pathogenesis of diabetes and its associated complications (English)

1 reference

21 August 2017

0 references

1 reference

Sandip Patel

1 reference

21 August 2017

Dev Santani

series ordinal

1 reference

21 August 2017

publication date

1 July 2009

1 reference

21 August 2017

published in

Pharmacological Reports

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

595-603

1 reference

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Role of aldosterone in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

TNFalpha decreases alphaMHC expression by a NO mediated pathway: role of E-box transcription factors for cardiomyocyte specific gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Production of superoxide and nitric oxide by granulocytes in non-insulin-dependent diabetic patients with and without diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Proteome Analysis of Interleukin-1 -Induced Changes in Protein Expression in Rat Islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

NF-kappaB in neuronal plasticity and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The role of oxidative stress and NF-kappaB activation in late diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Administration of NF-kappaB decoy inhibits pancreatic activation of NF-kappaB and prevents diabetogenesis by alloxan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Glucose and diabetic vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Antioxidants attenuate the plasma cytokine response to exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Oxidative stress and programmed cell death in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Advanced glycation end-products and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Enhanced inflammatory response via activation of NF-kappaB in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970111-2

7 January 2021

10.1016/S1734-1140(09)70111-2

Identifiers

DOI

1 reference

21 August 2017

1 reference